(Q47973486)

English

Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction

scientific article published in June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

0 references

Charles A. Dinarello

3

object named as

Dinarello CA

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

author name string

Jouvenne P

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

Vannier E

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

Miossec P

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

41

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

1083-1089

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Autoantibodies to cytokines--friends or foes?

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Interleukin 1 signaling occurs exclusively via the type I receptor

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

The histopathology of Sjögren's syndrome in labial salivary gland biopsies

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199806%2941%3A6%3C1083%3A%3AAID-ART15%3E3.0.CO%3B2-9

21 January 2018

Identifiers

10.1002/1529-0131(199806)41:6<1083::AID-ART15>3.0.CO;2-9

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9627018

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47973486&oldid=2179636190"